{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:59:11Z","timestamp":1788829151149,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T00:00:00Z","timestamp":1523836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007827","name":"American College of Gastroenterology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10620-018-5042-3","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T11:00:15Z","timestamp":1523876415000},"page":"1551-1557","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Hepatitis B Virus Screening and Reactivation in a National VA Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Antagonists"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2318-3714","authenticated-orcid":false,"given":"Rajesh","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith Y.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhada","family":"Sansgiry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashem B.","family":"El-Serag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason K.","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,16]]},"reference":[{"key":"5042_CR1","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1136\/gut.2004.040675","volume":"53","author":"M Esteve","year":"2004","unstructured":"Esteve M, Saro C, Gonzalez-Huix F, et al. Chronic hepatitis B reactivation following infliximab therapy in Crohn\u2019s disease patients: need for primary prophylaxis. Gut. 2004;53:1363\u20131365.","journal-title":"Gut"},{"key":"5042_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00535-008-2165-x","volume":"43","author":"K Ojiro","year":"2008","unstructured":"Ojiro K, Naganuma M, Ebinuma H, et al. Reactivation of hepatitis B in a patient with Crohn\u2019s disease treated using infliximab. J Gastroenterol. 2008;43:397\u2013401.","journal-title":"J Gastroenterol"},{"key":"5042_CR3","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1002\/ibd.20202","volume":"13","author":"M Esteve","year":"2007","unstructured":"Esteve M, Loras C, Gonzalez-Huix F. Lamivudine resistance and exacerbation of hepatitis B in infliximab-treated Crohn\u2019s disease patient. Inflamm Bowel Dis. 2007;13:1450\u20131451.","journal-title":"Inflamm Bowel Dis"},{"key":"5042_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1365-2893.2012.01643.x","volume":"20","author":"F Morisco","year":"2013","unstructured":"Morisco F, Castiglione F, Rispo A, et al. Effect of immunosuppressive therapy on patients with inflammatory bowel diseases and hepatitis B or C virus infection. J Viral Hepat. 2013;20:200\u2013208.","journal-title":"J Viral Hepat"},{"key":"5042_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.crohns.2010.03.001","volume":"4","author":"KH Katsanos","year":"2010","unstructured":"Katsanos KH, Tsianos VE, Zois CD, et al. Inflammatory bowel disease and hepatitis B and C in Western Balkans: a referral centre study and review of the literature. J Crohns Colitis. 2010;4:450\u2013465.","journal-title":"J Crohns Colitis"},{"key":"5042_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.crohns.2012.03.001","volume":"7","author":"A Papa","year":"2013","unstructured":"Papa A, Felice C, Marzo M, et al. Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-alpha agents. J Crohns Colitis. 2013;7:113\u2013119.","journal-title":"J Crohns Colitis"},{"key":"5042_CR7","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/ibd.21147","volume":"16","author":"JB Chevaux","year":"2010","unstructured":"Chevaux JB, Nani A, Oussalah A, et al. Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France. Inflamm Bowel Dis. 2010;16:916\u2013924.","journal-title":"Inflamm Bowel Dis"},{"key":"5042_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10096-008-0628-x","volume":"28","author":"C Garcia-Vidal","year":"2009","unstructured":"Garcia-Vidal C, Rodriguez-Fernandez S, Teijon S, et al. Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention. Eur J Clin Microbiol Infect Dis. 2009;28:331\u2013337.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5042_CR9","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/gut.2010.208413","volume":"59","author":"C Loras","year":"2010","unstructured":"Loras C, Gisbert JP, Minguez M, et al. Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy. Gut. 2010;59:1340\u20131346.","journal-title":"Gut"},{"key":"5042_CR10","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","volume":"8","author":"JF Rahier","year":"2014","unstructured":"Rahier JF, Magro F, Abreu C, et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2014;8:443\u2013468.","journal-title":"J Crohns Colitis"},{"key":"5042_CR11","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.dld.2014.07.006","volume":"46","author":"M Have van der","year":"2014","unstructured":"van der Have M, Belderbos TD, Fidder HH, et al. Screening prior to biological therapy in Crohn\u2019s disease: adherence to guidelines and prevalence of infections. Results from a multicentre retrospective study. Dig Liver Dis. 2014;46:881\u2013886.","journal-title":"Dig Liver Dis"},{"key":"5042_CR12","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1445-5994.2009.02114.x","volume":"41","author":"A Gupta","year":"2011","unstructured":"Gupta A, Macrae FA, Gibson PR. Vaccination and screening for infections in patients with inflammatory bowel disease: a survey of Australian gastroenterologists. Intern Med J. 2011;41:462\u2013467.","journal-title":"Intern Med J"},{"key":"5042_CR13","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/ibd.21824","volume":"18","author":"BP Vaughn","year":"2012","unstructured":"Vaughn BP, Doherty GA, Gautam S, et al. Screening for tuberculosis and hepatitis B prior to the initiation of anti-tumor necrosis therapy. Inflamm Bowel Dis. 2012;18:1057\u20131063.","journal-title":"Inflamm Bowel Dis"},{"key":"5042_CR14","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1007\/s10620-014-3174-7","volume":"59","author":"JK Hou","year":"2014","unstructured":"Hou JK, Tan M, Stidham RW, et al. Accuracy of diagnostic codes for identifying patients with ulcerative colitis and Crohn\u2019s disease in the Veterans Affairs Health Care System. Dig Dis Sci. 2014;59:2406\u20132410.","journal-title":"Dig Dis Sci"},{"key":"5042_CR15","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1200\/JOP.2011.000450","volume":"8","author":"JP Hwang","year":"2012","unstructured":"Hwang JP, Fisch MJ, Zhang H, et al. Low rates of hepatitis B virus screening at the onset of chemotherapy. J Oncol Pract. 2012;8:e32\u2013e39.","journal-title":"J Oncol Pract"},{"key":"5042_CR16","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/SMJ.0b013e318238b608","volume":"104","author":"JG Stine","year":"2011","unstructured":"Stine JG, Bass M, Ibrahim D, et al. Dermatologists\u2019 awareness of and screening practices for hepatitis B virus infection before initiating tumor necrosis factor-alpha inhibitor therapy. South Med J. 2011;104:781\u2013788.","journal-title":"South Med J"},{"key":"5042_CR17","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/acr.20209","volume":"62","author":"JG Stine","year":"2010","unstructured":"Stine JG, Khokhar OS, Charalambopoulos J, et al. Rheumatologists\u2019 awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy. Arthritis Care Res. 2010;62:704\u2013711.","journal-title":"Arthritis Care Res"},{"key":"5042_CR18","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1053\/j.gastro.2014.10.038","volume":"148","author":"RP Perrillo","year":"2015","unstructured":"Perrillo RP, Gish R, Falck-Ytter YT. American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology. 2015;148:e3.","journal-title":"Gastroenterology"},{"key":"5042_CR19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/cid\/cix295","volume":"65","author":"AJ Noska","year":"2017","unstructured":"Noska AJ, Belperio PS, Loomis TP, et al. Prevalence of Human Immunodeficiency Virus, Hepatitis C Virus, and Hepatitis B Virus among homeless and nonhomeless United States Veterans. Clin Infect Dis. 2017;65:252\u2013258.","journal-title":"Clin Infect Dis"},{"key":"5042_CR20","first-page":"1","volume":"57","author":"CM Weinbaum","year":"2008","unstructured":"Weinbaum CM, Williams I, Mast EE, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008;57:1\u201320.","journal-title":"MMWR Recomm Rep"},{"key":"5042_CR21","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1007\/s10620-009-1074-z","volume":"55","author":"S Thirumurthi","year":"2010","unstructured":"Thirumurthi S, Chowdhury R, Richardson P, et al. Validation of ICD-9-CM diagnostic codes for inflammatory bowel disease among veterans. Dig Dis Sci. 2010;55:2592\u20132598.","journal-title":"Dig Dis Sci"},{"key":"5042_CR22","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/ibd.20021","volume":"13","author":"LJ Herrinton","year":"2007","unstructured":"Herrinton LJ, Liu L, Lafata JE, et al. Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings. Inflamm Bowel Dis. 2007;13:451\u2013461.","journal-title":"Inflamm Bowel Dis"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-018-5042-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5042-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5042-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T19:54:06Z","timestamp":1555358046000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-018-5042-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,16]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["5042"],"URL":"https:\/\/doi.org\/10.1007\/s10620-018-5042-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,16]]},"assertion":[{"value":"11 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}